Long Trinh

1.0k total citations
22 papers, 716 citations indexed

About

Long Trinh is a scholar working on Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Long Trinh has authored 22 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Long Trinh's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (6 papers) and Advanced Breast Cancer Therapies (4 papers). Long Trinh is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (6 papers) and Advanced Breast Cancer Therapies (4 papers). Long Trinh collaborates with scholars based in United States, Vietnam and United Kingdom. Long Trinh's co-authors include Shibin Ma, Runqing Lu, Simanta Pathak, Marcus R. Clark, Alessandra Ferrajoli, Malay Mandal, Michael J. Keating, Zeev Estrov, Susan Lerner and William G. Wierda and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Long Trinh

22 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Long Trinh United States 11 296 235 234 156 149 22 716
Hadwiga Nowotny Austria 9 224 0.8× 167 0.7× 215 0.9× 152 1.0× 327 2.2× 12 701
Annet Simons Netherlands 17 154 0.5× 111 0.5× 198 0.8× 96 0.6× 153 1.0× 29 800
Stephanie A. Smoley United States 16 407 1.4× 304 1.3× 571 2.4× 91 0.6× 302 2.0× 44 908
Claudia Schöllkopf Denmark 13 246 0.8× 109 0.5× 192 0.8× 56 0.4× 279 1.9× 31 753
J Sklar United States 11 526 1.8× 286 1.2× 366 1.6× 105 0.7× 100 0.7× 13 933
Noriaki Yoshida Japan 20 308 1.0× 450 1.9× 130 0.6× 63 0.4× 295 2.0× 65 1.2k
Pierre‐Yves Le Prise France 11 185 0.6× 171 0.7× 100 0.4× 76 0.5× 257 1.7× 14 633
K Weber-Matthiesen Germany 19 552 1.9× 219 0.9× 341 1.5× 113 0.7× 214 1.4× 33 1.1k
MY Mapara Germany 10 444 1.5× 161 0.7× 131 0.6× 158 1.0× 99 0.7× 11 795
Pilar Martı́nez Spain 8 190 0.6× 104 0.4× 221 0.9× 29 0.2× 181 1.2× 23 638

Countries citing papers authored by Long Trinh

Since Specialization
Citations

This map shows the geographic impact of Long Trinh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Trinh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Trinh more than expected).

Fields of papers citing papers by Long Trinh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Trinh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Trinh. The network helps show where Long Trinh may publish in the future.

Co-authorship network of co-authors of Long Trinh

This figure shows the co-authorship network connecting the top 25 collaborators of Long Trinh. A scholar is included among the top collaborators of Long Trinh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Trinh. Long Trinh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran-Ngoc, H., et al.. (2025). Assessing the impact of upstream reservoirs on streamflow in the Mekong River Basin. Journal of Water and Climate Change. 16(4). 1404–1421. 1 indexed citations
2.
Huong, Vu Thi Lan, Hong Khanh Dieu Nguyen, Long Trinh, et al.. (2024). Antibiotic prescribing practices of medical doctors in a resource-limited setting and the influence of individual perceptions and stewardship support: a survey in three tertiary hospitals in Vietnam. JAC-Antimicrobial Resistance. 6(2). dlae064–dlae064. 1 indexed citations
3.
4.
Jain, Preetesh, Michael J. Keating, Philip A. Thompson, et al.. (2015). High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome. American Journal of Hematology. 90(6). 471–477. 3 indexed citations
5.
Benjamini, Ohad, Preetesh Jain, Long Trinh, et al.. (2014). Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leukemia & lymphoma. 56(6). 1643–1650. 102 indexed citations
6.
Lipson, Jafi A., Michael G. Ozawa, Sunita Pal, et al.. (2014). Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients. Annals of Surgical Oncology. 22(2). 377–382. 91 indexed citations
7.
Ohanian, Maro, Hagop M. Kantarjian, Alfonso Quintás‐Cardama, et al.. (2013). Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase. Clinical Lymphoma Myeloma & Leukemia. 14(2). 155–162.e1. 34 indexed citations
8.
Benjamini, Ohad, Long Trinh, Preetesh Jain, et al.. (2013). Second Cancers (SC) Affect the Clinical Outcome of Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Frontline FCR Therapy. Clinical Lymphoma Myeloma & Leukemia. 13. S365–S366. 2 indexed citations
9.
Chae, Young Kwang, Long Trinh, Michael J. Keating, & Zeev Estrov. (2012). Concurrent Use of Aspirin with the Fludarabine, Cyclophophamide, Rituximab (FCR) Regimen Improves Outcome in Patients with Relapsed/Refractory CLL.. Blood. 120(21). 2904–2904. 2 indexed citations
11.
Trinh, Long, Young Kwang Chae, Preetesh Jain, et al.. (2012). Second Cancers Affect the Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline FCR-Based Therapy.. Blood. 120(21). 2900–2900. 1 indexed citations
12.
Pathak, Simanta, Shibin Ma, Long Trinh, et al.. (2011). IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia. PLoS ONE. 6(7). e22628–e22628. 36 indexed citations
13.
Kantarjian, Hagop M., Alfonso Quintás‐Cardama, Elias Jabbour, et al.. (2011). Clinical Significance of Myelosuppression Associated with the Use of Dasatinib and Nilotinib As Initial Therapy in Chronic Phase (CP) of Chronic Myeloid Leukemia (CML). Blood. 118(21). 2761–2761. 1 indexed citations
14.
Ohanian, Maro, Hagop M. Kantarjian, Alfonso Quintás‐Cardama, et al.. (2011). Frontline Tyrosine Kinase Inhibitors (TKI) As Initial Therapy for Patients with Chronic Myeloid Leukemia in Accelerated Phase (CML-AP),. Blood. 118(21). 3779–3779. 2 indexed citations
16.
Ma, Shibin, Simanta Pathak, Malay Mandal, et al.. (2010). Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression. Molecular and Cellular Biology. 30(17). 4149–4158. 98 indexed citations
17.
Pathak, Simanta, Shibin Ma, Long Trinh, & Runqing Lu. (2008). A Role for Interferon Regulatory Factor 4 in Receptor Editing. Molecular and Cellular Biology. 28(8). 2815–2824. 22 indexed citations
19.
Ma, Shibin, et al.. (2006). IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development. The Journal of Immunology. 177(11). 7898–7904. 74 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026